1. Home
  2. BPYPP vs FBIOP Comparison

BPYPP vs FBIOP Comparison

Compare BPYPP & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Property Partners L.P.

BPYPP

Brookfield Property Partners L.P.

HOLD

Current Price

$15.21

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIOP

Fortress Biotech Inc.

N/A

Current Price

$13.26

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BPYPP
FBIOP
Founded
N/A
N/A
Country
Bermuda
United States
Employees
30200
101
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BPYPP
FBIOP
Price
$15.21
$13.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.9K
15.0K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.01
$4.72
52 Week High
$16.73
$14.64

Technical Indicators

Market Signals
Indicator
BPYPP
FBIOP
Relative Strength Index (RSI) 47.15 53.02
Support Level $14.53 $12.50
Resistance Level $15.33 $14.64
Average True Range (ATR) 0.44 0.50
MACD -0.00 -0.11
Stochastic Oscillator 44.17 66.47

Price Performance

Historical Comparison
BPYPP
FBIOP

About BPYPP Brookfield Property Partners L.P.

Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: